Occudo Quantitative Strategies’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Occudo Quantitative Strategies’s Portfolio PRTK Stock Details PRTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-15,722	Closed	-$29.4K	–	1282
2022 Q4	$29.4K	Sell	15,722 -31,442	-67%	-$78.4K	﹤0.01%	907
2022 Q3	$121K	Buy	47,164 +25,075	+114%	+$62.4K	0.01%	1021
2022 Q2	$43K	Buy	22,089 +1,835	+9%	+$4K	﹤0.01%	1080
2022 Q1	$60K	Buy	+20,254	New	+$76.2K	0.01%	1064
2021 Q2	–	Sell	-28,530	Closed	-$201K	–	1098
2021 Q1	$201K	Buy	28,530 +1,678	+6%	+$12.1K	0.04%	624
2020 Q4	$168K	Buy	+26,852	New	+$158K	0.05%	565

Other funds holding PRTK

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

GAI

General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Occudo Quantitative Strategies's PRTK Position: Q1 2023 in Review

Occudo Quantitative Strategies sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q1 2023, closing a stake of 15,722 shares — an estimated $29.4K sold.

Occudo Quantitative Strategies first reported a position in PRTK in Q4 2020 and held it in 6 quarters. The position peaked at $201K in Q1 2021. 63 funds tracked by Wall St. Rank hold PRTK as of Q1 2023.

Occudo Quantitative Strategies reported no remaining Paratek Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
Occudo Quantitative Strategies sold 15,722 Paratek Pharmaceuticals, Inc. shares in Q1 2023, an estimated $29.4K.
Occudo Quantitative Strategies first reported a position in Paratek Pharmaceuticals, Inc. in Q4 2020 and held it in 6 quarters.
Occudo Quantitative Strategies's Paratek Pharmaceuticals, Inc. position peaked at $201K in Q1 2021.
63 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q1 2023.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2023, filed 15 May 2023.